These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices. Rammes G, Hasenjäger A, Sroka-Saidi K, Deussing JM, Parsons CG. Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164 [Abstract] [Full Text] [Related]
4. MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD). Parsons CG, Ruitenberg M, Freitag CE, Sroka-Saidi K, Russ H, Rammes G. Neuropharmacology; 2015 May; 92():158-69. PubMed ID: 25634238 [Abstract] [Full Text] [Related]
5. The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (Aβ) species on long-term potentiation (LTP). Rammes G, Seeser F, Mattusch K, Zhu K, Haas L, Kummer M, Heneka M, Herms J, Parsons CG. Neuropharmacology; 2018 Sep 15; 140():184-192. PubMed ID: 30016667 [Abstract] [Full Text] [Related]
6. Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats. Liu XJ, Yuan L, Yang D, Han WN, Li QS, Yang W, Liu QS, Qi JS. Synapse; 2013 Sep 15; 67(9):626-36. PubMed ID: 23620224 [Abstract] [Full Text] [Related]
7. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease. Li S, Jin M, Liu L, Dang Y, Ostaszewski BL, Selkoe DJ. Acta Neuropathol Commun; 2018 Nov 08; 6(1):121. PubMed ID: 30409172 [Abstract] [Full Text] [Related]
8. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease. Gu XH, Xu LJ, Liu ZQ, Wei B, Yang YJ, Xu GG, Yin XP, Wang W. Behav Brain Res; 2016 Sep 15; 311():309-321. PubMed ID: 27233830 [Abstract] [Full Text] [Related]
9. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2. Isono T, Yamashita N, Obara M, Araki T, Nakamura F, Kamiya Y, Alkam T, Nitta A, Nabeshima T, Mikoshiba K, Ohshima T, Goshima Y. Neurosci Res; 2013 Nov 15; 77(3):180-5. PubMed ID: 23994236 [Abstract] [Full Text] [Related]
10. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers. Townsend M, Cleary JP, Mehta T, Hofmeister J, Lesne S, O'Hare E, Walsh DM, Selkoe DJ. Ann Neurol; 2006 Dec 15; 60(6):668-76. PubMed ID: 17192927 [Abstract] [Full Text] [Related]
11. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss. Freund RK, Gibson ES, Potter H, Dell'Acqua ML. Mol Pharmacol; 2016 May 15; 89(5):552-9. PubMed ID: 26957206 [Abstract] [Full Text] [Related]
12. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease. Wang X, Hu X, Yang Y, Takata T, Sakurai T. Exp Neurol; 2015 Sep 15; 271():145-54. PubMed ID: 26057947 [Abstract] [Full Text] [Related]
13. Lack of support for bexarotene as a treatment for Alzheimer's disease. O'Hare E, Jeggo R, Kim EM, Barbour B, Walczak JS, Palmer P, Lyons T, Page D, Hanna D, Meara JR, Spanswick D, Guo JP, McGeer EG, McGeer PL, Hobson P. Neuropharmacology; 2016 Jan 15; 100():124-30. PubMed ID: 26025659 [Abstract] [Full Text] [Related]
14. Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway. Jiang L, Huang M, Xu S, Wang Y, An P, Feng C, Chen X, Wei X, Han Y, Wang Q. Mol Neurobiol; 2016 Aug 15; 53(6):3832-3841. PubMed ID: 26160762 [Abstract] [Full Text] [Related]
15. The effect of chronic stimulation of serotonin receptor type 7 on recognition, passive avoidance memory, hippocampal long-term potentiation, and neuronal apoptosis in the amyloid β protein treated rat. Shahidi S, Asl SS, Komaki A, Hashemi-Firouzi N. Psychopharmacology (Berl); 2018 May 15; 235(5):1513-1525. PubMed ID: 29637287 [Abstract] [Full Text] [Related]
16. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease. Scott-McKean JJ, Surewicz K, Choi JK, Ruffin VA, Salameh AI, Nieznanski K, Costa ACS, Surewicz WK. Neurobiol Dis; 2016 Jul 15; 91():124-131. PubMed ID: 26949218 [Abstract] [Full Text] [Related]
17. Co-injection of Aβ1-40 and ApoE4 impaired spatial memory and hippocampal long-term potentiation in rats. Wu M, He Y, Zhang J, Yang J, Qi J. Neurosci Lett; 2017 May 01; 648():47-52. PubMed ID: 28356228 [Abstract] [Full Text] [Related]
18. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death. Wang X, Hu X, Yang Y, Takata T, Sakurai T. Brain Res; 2016 Jul 15; 1643():1-9. PubMed ID: 27130898 [Abstract] [Full Text] [Related]
19. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z. Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747 [Abstract] [Full Text] [Related]
20. Protective effects of EphB2 on Aβ1-42 oligomer-induced neurotoxicity and synaptic NMDA receptor signaling in hippocampal neurons. Geng D, Kang L, Su Y, Jia J, Ma J, Li S, Du J, Cui H. Neurochem Int; 2013 Oct 23; 63(4):283-90. PubMed ID: 23831214 [Abstract] [Full Text] [Related] Page: [Next] [New Search]